Literature DB >> 21518758

Tapasin discriminates peptide-human leukocyte antigen-A*02:01 complexes formed with natural ligands.

Gustav Roder1, Linda Geironson, Michael Rasmussen, Mikkel Harndahl, Søren Buus, Kajsa Paulsson.   

Abstract

A plethora of peptides are generated intracellularly, and most peptide-human leukocyte antigen (HLA)-I interactions are of a transient, unproductive nature. Without a quality control mechanism, the HLA-I system would be stressed by futile attempts to present peptides not sufficient for the stable peptide-HLA-I complex formation required for long term presentation. Tapasin is thought to be central to this essential quality control, but the underlying mechanisms remain unknown. Here, we report that the N-terminal region of tapasin, Tpn(1-87), assisted folding of peptide-HLA-A*02:01 complexes according to the identity of the peptide. The facilitation was also specific for the identity of the HLA-I heavy chain, where it correlated to established tapasin dependence hierarchies. Two large sets of HLA-A*02:01 binding peptides, one extracted from natural HLA-I ligands from the SYFPEITHI database and one consisting of medium to high affinity non-SYFPEITHI ligands, were studied in the context of HLA-A*02:01 binding and stability. We show that the SYFPEITHI peptides induced more stable HLA-A*02:01 molecules than the other ligands, although affinities were similar. Remarkably, Tpn(1-87) could functionally discriminate the selected SYFPEITHI peptides from the other peptide binders with high sensitivity and specificity. We suggest that this HLA-I- and peptide-specific function, together with the functions exerted by the more C-terminal parts of tapasin, are major features of tapasin-mediated HLA-I quality control. These findings are important for understanding the biogenesis of HLA-I molecules, the selection of presented T-cell epitopes, and the identification of immunogenic targets in both basic research and vaccine design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518758      PMCID: PMC3121515          DOI: 10.1074/jbc.M111.230151

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes.

Authors:  B Ortmann; J Copeman; P J Lehner; B Sadasivan; J A Herberg; A G Grandea; S R Riddell; R Tampé; T Spies; J Trowsdale; P Cresswell
Journal:  Science       Date:  1997-08-29       Impact factor: 47.728

2.  Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin.

Authors:  A G Grandea; P J Lehner; P Cresswell; T Spies
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

3.  Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding.

Authors:  A Stryhn; L O Pedersen; T Romme; C B Holm; A Holm; S Buus
Journal:  Eur J Immunol       Date:  1996-08       Impact factor: 5.532

4.  Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.

Authors:  J W Lewis; A Neisig; J Neefjes; T Elliott
Journal:  Curr Biol       Date:  1996-07-01       Impact factor: 10.834

5.  Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.

Authors:  S H van der Burg; M J Visseren; R M Brandt; W M Kast; C J Melief
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

6.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

7.  Cloning and functional characterization of a subunit of the transporter associated with antigen processing.

Authors:  S Li; H O Sjögren; U Hellman; R F Pettersson; P Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

8.  Tapasin edits peptides on MHC class I molecules by accelerating peptide exchange.

Authors:  P V K Praveen; Rakina Yaneva; Hubert Kalbacher; Sebastian Springer
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

9.  A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.

Authors:  A L Peace-Brewer; L G Tussey; M Matsui; G Li; D G Quinn; J A Frelinger
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

Review 10.  Quality control of MHC class I maturation.

Authors:  Kajsa M Paulsson; Ping Wang
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

View more
  4 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.

Authors:  Camilla Thuring; Elna Follin; Linda Geironson; Eva Freyhult; Victoria Junghans; Mikkel Harndahl; Søren Buus; Kajsa M Paulsson
Journal:  Br J Cancer       Date:  2015-08-27       Impact factor: 7.640

Review 3.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

4.  Exchange catalysis by tapasin exploits conserved and allele-specific features of MHC-I molecules.

Authors:  Huan Lan; Esam T Abualrous; Jana Sticht; Laura Maria Arroyo Fernandez; Tamina Werk; Christoph Weise; Martin Ballaschk; Peter Schmieder; Bernhard Loll; Christian Freund
Journal:  Nat Commun       Date:  2021-07-09       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.